title: Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.
authors.affiliation: Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France; Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Guibert
authors.affiliation: Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Pradines
authors.affiliation: Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Casanova
authors.affiliation: Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.
authors.forename: Magali
authors.initials: M
authors.lastname: Farella
authors.affiliation: Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.
authors.forename: Laura
authors.initials: L
authors.lastname: Keller
authors.affiliation: Drug Development Department, Gustave Roussy Cancer Campus, Paris-Sud University, Villejuif, France.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
authors.affiliation: Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France; Laboratoire de Biologie Médicale Oncologique, Institut Universitaire du Cancer de Toulouse, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Favre
authors.affiliation: Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France; Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France. Electronic address: mazieres.j@chu-toulouse.fr.
authors.forename: Julien
authors.initials: J
authors.lastname: Mazières
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D000074141:Circulating Tumor DNA / Q000097:blood / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D009154:Mutation; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D011379:Prognosis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*
chemical_list: D000074141:Circulating Tumor DNA; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf